Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Total 13F shares
-
154,603,092
-
Share change
-
+157,862
-
Total reported value
-
$9,233,952,173
-
Put/Call ratio
-
15%
-
Price per share
-
$59.72
-
Number of holders
-
261
-
Value change
-
+$80,601,155
-
Number of buys
-
138
-
Number of sells
-
115
Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q4 2017
As of 31 Dec 2017,
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) was held by
261 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
154,603,092 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., Vanguard Group Inc, OppenheimerFunds, Inc., FMR LLC, STATE STREET CORP, PointState Capital LP, JANUS HENDERSON GROUP PLC, Camber Capital Management LLC, and NORGES BANK.
This page lists
261
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.